Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience
Robert L. Fine(Columbia University Irving Medical Center), Anthony P. Gulati(Columbia University Irving Medical Center), Benjamin A. Krantz(Columbia University Irving Medical Center), Rebecca A. Moss(Rutgers Cancer Institute of New Jersey), Stephen M. Schreibman(Morristown Medical Center), Dawn Tsushima(Columbia University Irving Medical Center), Kelley B. Mowatt(Columbia University Irving Medical Center), Richard D. Dinnen(Columbia University Irving Medical Center), Yuehua Mao(Columbia University Irving Medical Center), Peter D. Stevens, Beth Schrope, John Allendorf, James A. Lee, William H. Sherman(Columbia University Irving Medical Center), John A. Chabot
Cited by 257